NUTRITION, OXIDATIVE STRESS AND INTESTINAL DYSBIOSIS: INFLUENCE OF DIET ON GUT MICROBIOTA IN INFLAMMATORY BOWEL DISEASES. by Tomasello, G. et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec; 160(4):461-466.
461
Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut 
microbiota in inflammatory bowel diseases
Giovanni Tomaselloa,b,c,e, Margherita Mazzolaa, Angelo Leonei, Emanuele Sinagrad,e, Giovanni Zummoa, Felicia Farinaa, 
Provvidenza Damianic, Francesco Cappelloa,e, Alice Gerges Geageaa,f, Abdo Jurjusf, Tarek Bou Assig, Massimiliano Messinah, 
Francesco Carinia,c
Background. Microbiota refers to the population of microorganisms (bacteria, viruses and fungi) that inhabit the entire 
gastrointestinal tract, more particularly the colon whose role is to maintain the integrity of the intestinal mucosa and 
control the proliferation of pathogenic bacteria. Alteration in the composition of the gut microbiota is called dysbiosis. 
Dysbiosis redisposes to inflammatory bowel diseases such as ulcerative colitis, Crohn disease and indeterminate colitis. 
Methods. The purpose of this literature review is to elucidate the influence of diet on the composition of the gastro-
intestinal microbiota in the healthy gut and the role of diet in the development of dysbiosis.
Conclusion. The “Western diet”, in particular a low - fiber high fat/high carbohydrate diet is one factor that can lead to 
severe dysbiosis. In contrast, “mediterranean” and vegetarian diets that includes abundant fruits, vegetables, olive oil 
and oily fish are known for their anti-inflammatory effects and could prevent dysbiosis and subsequent inflammatory 
bowel disease.
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INTRODUCTION
Many areas of current research focus on the the influ-
ence and effects of dietary habits on human health, espe-
cially in Western countries, where he largest proportions 
of so- called “junk food” consumers reside. The “western 
diet”, mainly refined carbohydrates, simple sugars and 
saturated fats, is linked to various metabolic disorders.
The purpose of this review is to illustrate how dietary 
habits can influence the composition of the intestinal 
microbiota leading to dysbiosis and inflammatory bowel 
disease (IBD). After a brief overview of the gut anatomy 
and the role of the microbiota in healthy gut, this review 
depicts how the microbiota composition varies based on 
diet and how this in turn may lead to the onset of systemic 
metabolic disorders and/or IBD.
GUT MORPHOLOGY
The habitat of the gut microbiota is represented by the 
intestine. The latter consists of two major portions: the 
small intestine, divided into duodenum, jejunum and il-
eum responsible for digestion and nutrient absorption and 
the large intestine, divided into cecum, colon and rectum 
is responsible for water absorption and formation of feces. 
The intestinal wall is composed of four superimposed lay-
ers: from the outermost layer, we find the serosa, the mus-
cularis propria, the submucosa and finally the mucosa. 
The small intestine has villi created mainly in enterocytes 
which show on their surface, protrusions called microvilli. 
These protrusions increase the absorption surface and 
thus facilitate the digestive process and the absorption of 
nutrients. The large intestine epithelium comprises colo-
nocytes similar to the enterocytes. However, their main 
function is to absorb water. Colonocytes are arranged to 
form along goblet cells, simple tubular glands which se-
crete neutral mucus to lubricate the intestinal contents. 
The highest concentration of bacteria is found in the large 
intestine. For a more detailed description, please refer to 
specialized books1,2.
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MICROBIOTA
In the human gut, there are trillions of microorgan-
isms which together are known as microbiota3,4. Intestinal 
bacteria have the highest concentration, approximately 
100 trillion, with a density of 9x1013-14 and considerable 
biodiversity (approximately 1000 bacterial species). In 
the colon, there are around 160 to 500 different bacte-
rial species with a wide range of specific microbiological 
characteristics4-7.
The total microbiota genome is around 100 times 
greater in size than the human genome and is defined 
by the term microbiome7. During pregnancy, the fetal 
gut is sterile and therefore bacterial colonization and the 
acquisition of the microbiota occur at birth. During the 
passage through the birth canal, the neonatal intestine 
is colonized by the maternal, anal or vaginal flora that 
contain bacteria such as Bacteroidetes, Bifidobacterium, 
Prevotella and Lactobacillus spp.5,8. However, for babies de-
livered by cesarean section, intestinal colonization occurs 
mainly by bacteria from the skin and from the hospital 
environment8.
As long as babies are breastfed, gut microbiota con-
sists primarily of Bifidobacterium spp. This composi-
tion changes with the introduction of solid foods until 
they reach the final composition seen in adulthood8. 
However, in adults, the microbiota varies in number 
and species based on the location in the gastrointestinal 
tract. In the stomach, several microorganisms are present 
mainly Lactobacillus, Streptococcus, Helicobacter Pylori, 
Peptostreptococcus and Candida. In the duodenum, jeju-
num and proximal ileum there are mainly Lactobacillus 
and Streptococcus, while the distal ileum contains around 
107 to 108 bacteria including Streptococcus, Bacteroidetes, 
Actinomycinae, Corynebacteria and Clostridium. On the 
other hand, the colon contains around 1011 to 1012 bac-
teria mainly Clostridium Type IV and XIV, Bacteroidetes, 
Bifidobacterium and Enterobacteriaceae9. As a result, it 
is clear that most bacteria reside in the colon and they 
are divided into four main groups: Firmicutes, represents 
alone 64% of the microbiota; Bacteroidetes (23%); fol-
lowed by Actinobacteria and Proteobacteria9.
The microbiota plays a vital role in the health of the 
host. In fact, it controls the proliferation of pathogenic 
bacteria present in the intestinal tract (such as Clostridia 
or Colibacillacea) (ref.5,10), stimulates the immune system, 
regulates the absorption of nutrients11, regulates the host 
metabolism and physiology12, intervenes in the production 
of vitamins and enzymes such as vitamin K and biotin6, 
and in the synthesis of compounds useful for the trophism 
of colonic mucosa and required for cell renewal5,10.
Within the gut, the microbiota plays different roles, in-
cluding the fermentation of amino acids and saccharides, 
with the production of short-chain fatty acids (SCFAs), 
succinate, ethanol, H2, amines, lactate, phenols, thiols 
and indoles, disposal of hydrogen (as acetate H2S and 
methane) degradation of undigested proteins and carbo-
hydrates, and the transformation of bile acids8. Actually, 
the production of SCFAs, including butyrate, propio-
nate and acetate, plays an essential role in maintaining a 
healthy mucosa and the production of anti-inflammatory 
interleukins5,11. In brief, the SCFAs are derived from bacte-
Fig. 1. Role of gut microbiota in humans. Human gut microbiota plays roles: stimulates the immune systém and cell reneval, 
produces vitamins and enzymes (such as vitamin K and biotin), enhances the synthesis of compounds useful for the trophism 
of colonic mucosa, and regulates the absorption of nutrients. One of its most important functions, however, is to regulate and 
influence the host’s metabolism and to control the proliferation of pathogenic bacteria found in the gastrointestinal tract (such 
as Clostridia or Colibacillacea).
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rial fermentation of dietary carbohydrates. This fermen-
tation process occurs in the colon by Lactobacilli and 
Bifidobacteria under anaerobic conditions5.
Moreover, butyric acid is the preferred source of 
energy for colonocytes. Butyric acid has an important 
anti-inflammatory effect and controls the proliferation, 
differentiation and apoptosis of colonocytes. In addition, 
it strengthens the defensive barrier of the colon by increas-
ing the production of mucin and antimicrobial peptides 
and by decreasing the intestinal epithelial permeability 
and increasing the expression of tight junction’s proteins5.
Another important function of the microbiota is to 
keep the concentration of pathogens within limits. This 
action is accomplished via various mechanisms including 
direct competition for nutrients, increase of the mucus lay-
er on the intestinal mucosa and through the development 
and the stimulation of the immune system, particularly 
of the gut associated lymphatic tissue (GALT) (ref.13).
DYSBIOSIS AND RELATED DISEASES
Any alteration of bowel eubiosis or in the composi-
tion of the microbiota is called dysbiosis. Actually, the 
composition of the microbiota depends on several factors 
including the structure of the host’s intestinal epithelium, 
peristalsis, dietary changes, age, genes, temperature, inter-
action between different bacterial species, response of the 
immune system in particular T and B cells, administration 
of antibiotics or radiation and chemotherapy drugs, envi-
ronmental, physical and finally psychological stress5,6,14. 
Consequently, dysbiosis causes an alteration of the in-
tercellular tight junctions that are responsible for keeping 
the integrity of the intestinal mucosa15 and its permeabil-
ity which is crucial to prevent the access of pathogens5. 
Otherwise there is activation of the MALT (Mucosal 
Associated Lymphatic Tissue) with activation of the in-
flammatory cascade (leukocytes, cytokines, TNF- α) and 
consequently massive tissue damage15.
Dysbiosis is also related to the development of a num-
ber of diseases including type 2 diabetes, allergies, fatty 
liver disease, obesity and IBD among others7. 
IBD, such as Crohn's disease (CD), ulcerative colitis 
(UC) and Indeterminate Colitis, are chronic and progres-
sive immune disorders related to alterations in (i) the 
composition of the microbiota (dysbiosis), (ii) immune 
response (iii) genetic and (iv) environmental factors10,16. 
It is estimated that there are 3.7 million people living with 
IBD in American and European populations16.
CD is an IBD that affects the entire gastrointestinal 
tract, from the mouth to the anus, with possible alterna-
tions in all four layers of the intestineand possible anal 
stenosis, fistulas, and/or abscesses. It is manifested by 
symptoms that include periods of remission and disease 
flare. On the other hand, UC is an IBD that affects the 
terminal portion of the gastrointestinal system, rectum 
and colon and, characterized by a hyperemic mucosa, 
exudate and erosions15-17.
The pathogenesis of IBD is still unclear. It is defined 
as a multifactorial disease. Contributing factors range 
from genetic (i.e. gene NOD2), to changes of microbiota 
composition, exposure to environmental stresses such as 
Fig. 2. Causes of dysbiosis and related diseases. Dysbiosis is a state of imbalance between the various organisms inhabiting the 
human gut. It can be caused by hereditary factors, some drugs such as antibiotics, radiotherapy and chemotherapy, age, but is 
mostly related to poor nutrition and physical and psychological stress which results in a dysregulation of the immune system. All 
of these predispose to the onset of conditions as type 2 diabetes, liver disease and especially inflammatory bowel disease (IBD) 
and colorectal cancer (CRC).
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cigarette smoking, diet, physical and psychological stress, 
surgery (i.e. appendectomy), sedentary lifestyle, personal 
hygiene and use of drugs6,16,18.
Another possible etiology of IBD is through oxidative 
stress which is characterized by the presence of reactive 
oxygen species (ROS). ROS (such as hydrogen peroxide, 
hydroxyl radical, superoxide anion and peroxynitrite) 
arise from incomplete reduction of oxygen19 and are of-
ten correlated with dysbiosis. It is believed that oxidative 
stress induced by ROS increases the inflammatory reac-
tion leading, probably through a positive feedback mecha-
nism, to an increased production of ROS and subsequent 
tissue damage20.
Several studies have shown a correlation between in-
creased oxidative stress and a Western-style diet rich in 
fats and refined sugars. These products in fact, if taken 
frequently and in large quantities, cause an increase of the 
inflammatory state with ROS production and subsequent 
amplification of the inflammatory cascade21-23.
Currently, there are also discussions about the po-
tential role of heat shock proteins (HSPs) in the patho-
genesis of IBD. HSPs are involved in various processes 
such as folding, translocation and degradation of intra-
cellular proteins under normal and stressful conditions. 
Being highly conserved molecules with similar sequences 
in bacterial and human orthologs (molecular mimicry), 
HSPs can stimulate an immune response, both innate and 
adaptive and hence primary targets of the autoimmune 
response5,21. Furthermore, intestinal dysbiosis is often ac-
companied by a reduction in obligate anaerobic bacteria 
and an increase in facultative anaerobes. A comparison 
between the resident gut microbiota in IBD patients with 
the microbiota of healthy subjects has shown that in IBD 
patients, there are fewer f phylum Firmicutes and a high-
er load of Enterobacteriaceae including E. coli4. Another 
study showed that CD patients had a decreased number 
of Faecalibacterium prausnitzii (Firmicutes) responsible for 
the production of butyric acid16. 
HOW NUTRITION AND DIET CAN INFLUENCE 
MICROBIOTA AND CORRECT DYSBIOSIS 
It is well known that a high fat/carb diet, low in fruits 
and vegetables increases the risk of metabolic disorders. 
In addition, it is well demonstrated that diet has a great in-
fluence (estimated at 57% compared with 12% for genetic 
factors) on the composition of the microbiota10. Targeted 
studies have shown that consumption of large amounts of 
fat and sugar in the long run, results in a degree of dys-
biosis and in a change of microbiota such as an increased 
number of Bacterioides spp and Ruminococcus torques22. 
Fig. 3. Food pyramid with daily and weekly consumption of food groups. The Mediterranean food pyramid summarizes the food 
groups that should be eaten within a week. At the base of the pyramid, we find that water should be consumed daily in large quanti-
ties (at least 1.5 l per day). Second to water, fruits, vegetables and whole grains should be consumed daily at every meal. Climbing 
further, we find herbs, extra virgin olive oil and dairy products, which should be consumed daily. At the top of the pyramid, we 
find animal products (fish, eggs and meat) and vegetables proteins, the consumption of which should be alternated and weekly. 
Finally, at the apex of the pyramid are the processed meats and sweets, whose consumption should be limited.
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Other studies have shown that a diet rich in saturated 
fatty acids and low in polyunsaturated fatty acids (derived 
from vegetable oils) induces dysbiosis with proliferation 
of Bilophila wadsworthia, leading to an inflammatory reac-
tion mediated by Th1 cells and colitis in mice13,16.
In addition, if we compare the Western diet which is 
high in fat, refined carbohydrates and animal protein, to 
Eastern diets based on carbohydrates derived from plants, 
vegetables, rice and fruits, we note that the Eastern popu-
lation microbiota has a higher prevalence of Prevotella 
spp. rather than Bacteriodes spp. compared to the Western 
population8,16. Furthermore, animal sources of protein and 
fat are associated with a greater number of Bacteriodes 
spp., while simple carbohydrates and fiber are mostly as-
sociated with an increase of Prevotella spp.8,16.
On the other hand, while the bacterial fermentation of 
carbohydrates produces SCFAs that maintains a healthy 
intestine, the fermentation of protein residues produces 
metabolites such as organic acids, phenolic compounds, 
indoles and ammonia which are deleterious and toxic for 
the intestine8.
It is well-demonstrated that diets high in fat and/or 
sugar destroy the intestinal microbiota, leading to dysbio-
sis and increased production of endotoxins23. Dysbiosis 
modifies the intestinal mucosa which becomes thinner 
and more permeable to pathogens and antigens with 
consequent establishment a low-grade but persistent, in-
flammation22. In contrast, a diet rich in vegetables and 
fibers, reduces the intestinal pH and prevents the growth 
of potential pathogenic bacteria such as strains of E. coli 
and other Enterobacteriaceae10. In brief, the literature is 
in support of the fact that microbiota is intimately related 
to food quality and that diet influences the composition 
of the microbiota and represents a source of luminal an-
tigens15. 
In a review in 2015, Tomasello et al.15 noted that a 
Western-style diet, high in refined carbohydrates, simple 
sugars, saturated fatty acids and omega 6 fatty acids and 
poor in fruits and vegetables, may be a trigger for UC and 
CD (ref.15). Similarly, according to Agus et al.22, exces-
sive consumption of animal protein is associated with an 
increased risk of developing CD; while the consumption 
of fruit and vegetables was inversely related15. Patients 
with CD also showed a shift in the microbiota, with an 
increased Proteobacteria and Bifidobacteria groups, and a 
decreased Firmicutes22.
For UC, in addition to the large consumption of re-
fined carbohydrates and simple sugars, the consumption 
of large amounts of fatty acids is also associated with an 
increased risk17.
An alteration of the relationship between the various 
categories of polyunsaturated fatty acids (PUFA), is as-
sociated with an increased risk of CD and UC (ref.16).
It is also reported that Vitamin D deficiency 
may play a role in the pathogenesis of IBD. In mice, 
Ananthakrishnan16 demonstrated that a deficiency of vi-
tamin D was associated with an increased risk of colitis, 
whereas Vitamin D supplementation had an anti-inflam-
matory effect in mice with colitis, due to the inhibition of 
pro inflammatory genes such as TNF genes16. 
In addition, the intake of PUFA and conjugated linole-
ic acid (CLA) appear to have numerous benefits in IBD 
patients because they have anti-inflammatory characteris-
tics15. In fact, they decrease the production of interferon-γ 
and prostaglandin E2 (ref.17) and modify the responsive-
ness of T cells15.
One diet pattern that is considered useful for the 
prevention/ improvement of intestinal diseases is the 
Mediterranean diet. This is characterized by a high in-
take of fruit and vegetables (rich in fiber, antioxidants and 
vitamins), olive oil and oily fish (rich in mono and poly-
unsaturated fatty acids), and whole grains and nuts15,24. It 
is based on the daily or weekly consumption of specific 
food groups according to the standardized food pyramid24.
Current research on probiotics, as a food supplement 
in addition to a mediterranean diet, showed that probiot-
ics (such as Lactobacillus Rhamnosus) changes the com-
position of the microbiota, thus allowing the return to 
eubiosis5. Also, prebiotic foods, which contains soluble 
fiber, helps maintaining intestinal eubiosis25. Prebiotics, 
for example inulin, are metabolized by the gut microbiota 
to form SCFAs including butyric acid. Tralongo et al.5 
showed that butyrate had a positive effect on the physi-
ological activity of colonocytes and that it had an anti-in-
flammatory effect (expressed by reducing the production 
of pro-inflammatory factors such as Nf-kb) making it a 
valuable ally in the treatment of IBD symptoms5.
CONCLUSION 
The role of nutrition in the prevention and im-
provement of IBD symptoms is widely demonstrated. 
Compared to the Western diet, there are clear benefits 
of the mediterranean or vegetarian diet rich in fruits, veg-
etables, fish oil, whole grains and olive oil, which provide 
nutrients such as vitamin D, essential fatty acids, miner-
als and fibers. These foods maintain a healthy intestinal 
microbiota preventing dysbiosis, which was deemed the 
basis of IBD. 
However, the true role of the Western diet in the de-
velopment of IBD has not yet been fully clarified and for 
this reason, it is advisable to undertake further studies.
The role of diet and probiotics supplementation in 
restoring the balance of intestinal flora and improving 
IBD symptoms is also well established. In addition to a 
healthy diet, it would be beneficial to take supplements to 
increase the levels of nutrients helpful in reducing inflam-
matory processes. 
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